151 related articles for article (PubMed ID: 28182106)
1. TNF-
Liu Z; Gao L; Wang P; Xie Z; Cen S; Li Y; Wu X; Wang L; Su H; Deng W; Wang S; Li D; Li J; Ouyang Y; Wu Y; Shen H
Stem Cells Int; 2017; 2017():4521324. PubMed ID: 28182106
[TBL] [Abstract][Full Text] [Related]
2. [Hyperactivation of PI3K/AKT/mTOR signal pathway impairs TNF-α-induced autophagy in mesenchymal stem cells from patients with ankylosing spondylitis].
Liu Z; Min S; Lu X; Cen S; Chen Z; Wang T; Li J; Zeng W; Qiu S
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Feb; 42(2):272-277. PubMed ID: 35365453
[TBL] [Abstract][Full Text] [Related]
3. MCP1 triggers monocyte dysfunctions during abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis.
Xie Z; Wang P; Li J; Li Y; Wang S; Wu X; Sun S; Cen S; Su H; Deng W; Liu Z; Ouyang Y; Wu Y; Shen H
J Mol Med (Berl); 2017 Feb; 95(2):143-154. PubMed ID: 27921117
[TBL] [Abstract][Full Text] [Related]
4. Abnormal inhibition of osteoclastogenesis by mesenchymal stem cells through the miR-4284/CXCL5 axis in ankylosing spondylitis.
Liu W; Wang P; Xie Z; Wang S; Ma M; Li J; Li M; Cen S; Tang S; Zheng G; Ye G; Wu X; Wu Y; Shen H
Cell Death Dis; 2019 Feb; 10(3):188. PubMed ID: 30804325
[TBL] [Abstract][Full Text] [Related]
5. Aberrant lncRNA-mRNA expression profile and function networks during the adipogenesis of mesenchymal stem cells from patients with ankylosing spondylitis.
Cen S; Cai M; Wang Y; Lu X; Chen Z; Chen H; Fang Y; Wu C; Qiu S; Liu Z
Front Genet; 2022; 13():991875. PubMed ID: 36246583
[No Abstract] [Full Text] [Related]
6. Elevated TRAF4 expression impaired LPS-induced autophagy in mesenchymal stem cells from ankylosing spondylitis patients.
Li J; Wang P; Xie Z; Yang R; Li Y; Wu X; Su H; Deng W; Wang S; Liu Z; Cen S; Ouyang Y; Wu Y; Shen H
Exp Mol Med; 2017 Jun; 49(6):e343. PubMed ID: 28604663
[TBL] [Abstract][Full Text] [Related]
7. SMAD-specific E3 ubiquitin ligase 2 promotes angiogenesis by facilitating PTX3 degradation in MSCs from patients with ankylosing spondylitis.
Ma M; Yang W; Cai Z; Wang P; Li H; Mi R; Jiang Y; Xie Z; Sui P; Wu Y; Shen H
Stem Cells; 2021 May; 39(5):581-599. PubMed ID: 33547700
[TBL] [Abstract][Full Text] [Related]
8. Increased BMPR1A Expression Enhances the Adipogenic Differentiation of Mesenchymal Stem Cells in Patients with Ankylosing Spondylitis.
Liu Z; Wang P; Cen S; Gao L; Xie Z; Wu X; Su H; Wu Y; Shen H
Stem Cells Int; 2019; 2019():4143167. PubMed ID: 31827527
[TBL] [Abstract][Full Text] [Related]
9. Triptolide attenuates inhibition of ankylosing spondylitis-derived mesenchymal stem cells on the osteoclastogenesis through modulating exosomal transfer of circ-0110634.
Ji W; Lu Y; Ma Z; Gan K; Liu Y; Cheng Y; Xu J; Liu S; Guo Y; Han S; Zhao Z; Xu H; Qi W
J Orthop Translat; 2022 Sep; 36():132-144. PubMed ID: 36185580
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
Leverkus M; Neumann M; Mengling T; Rauch CT; Bröcker EB; Krammer PH; Walczak H
Cancer Res; 2000 Feb; 60(3):553-9. PubMed ID: 10676636
[TBL] [Abstract][Full Text] [Related]
12. Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines.
Kang J; Kisenge RR; Toyoda H; Tanaka S; Bu J; Azuma E; Komada Y
Br J Haematol; 2003 Dec; 123(5):921-32. PubMed ID: 14632785
[TBL] [Abstract][Full Text] [Related]
13. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
MacFarlane M; Harper N; Snowden RT; Dyer MJ; Barnett GA; Pringle JH; Cohen GM
Oncogene; 2002 Oct; 21(44):6809-18. PubMed ID: 12360407
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.
Brost S; Zimmermann A; Koschny R; Sykora J; Stremmel W; Schirmacher P; Walczak H; Ganten TM
Pathol Res Pract; 2014 Feb; 210(2):83-91. PubMed ID: 24268735
[TBL] [Abstract][Full Text] [Related]
16. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
18. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
19. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
Sprick MR; Weigand MA; Rieser E; Rauch CT; Juo P; Blenis J; Krammer PH; Walczak H
Immunity; 2000 Jun; 12(6):599-609. PubMed ID: 10894160
[TBL] [Abstract][Full Text] [Related]
20. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
